Australia markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
23.55+0.12 (+0.51%)
At close: 04:00PM EDT
23.55 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts10101111
Avg. Estimate-0.67-0.69-2.64-2.89
Low estimate-0.76-0.84-3.5-3.58
High estimate-0.58-0.58-1.48-2.54
Year ago EPS-0.46-0.62-2.32-2.64
Revenue estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts881111
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202229/06/202229/09/202230/12/2022
Est. EPS-0.42-0.48-0.62-0.64
Actual EPS-0.46-0.62-0.66-0.59
Difference-0.04-0.14-0.040.05
Surprise %-9.50%-29.20%-6.50%7.80%
EPS trendCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Current estimate-0.67-0.69-2.64-2.89
7 days ago-0.67-0.69-2.64-2.9
30 days ago-0.67-0.68-2.68-2.95
60 days ago-0.66-0.67-2.64-2.8
90 days ago-0.66-0.67-2.64-2.8
EPS revisionsCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/A1
Up last 30 daysN/A1N/A2
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesCEREIndustrySector(s)S&P 500
Current qtr.-45.70%N/AN/AN/A
Next qtr.-11.30%N/AN/AN/A
Current year-13.80%N/AN/AN/A
Next year-9.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A